Esa-Pekka Pälvimäki
- Cellular and Molecular Neuroscience top 5%
- Molecular Biology
- Pharmacology
- Psychiatry and Mental health
- Biological Psychiatry top 10%
- Co-authors
- Jarmo HietalaErkka SyvälahtiMikko KuoppamäkiAki LaaksoB RothNaseem KhanSusan A. BerryM S Choudhary
- Topics
- Neurotransmitter Receptor Influence on Behavior (11 papers)Receptor Mechanisms and Signaling (7 papers)Treatment of Major Depression (3 papers)
- Journals
- Journal of Pharmacology and Experimental TherapeuticsNeuropsychopharmacologyPsychopharmacology
- Partner nations
- FinlandUnited States
In The Last Decade
Esa-Pekka Pälvimäki
12 papers receiving 425 citations
Peers
Comparison fields: 5 of 65
- Cellular and Molecular Neuroscience 295
- Molecular Biology 197
- Pharmacology 78
- Psychiatry and Mental health 66
- Biological Psychiatry 39
Countries citing papers authored by Esa-Pekka Pälvimäki
This map shows the geographic impact of Esa-Pekka Pälvimäki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Esa-Pekka Pälvimäki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Esa-Pekka Pälvimäki more than expected).
Fields of papers citing papers by Esa-Pekka Pälvimäki
This network shows the impact of papers produced by Esa-Pekka Pälvimäki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Esa-Pekka Pälvimäki. The network helps show where Esa-Pekka Pälvimäki may publish in the future.
Co-authorship network of co-authors of Esa-Pekka Pälvimäki
This figure shows the co-authorship network connecting the top 25 collaborators of Esa-Pekka Pälvimäki. A scholar is included among the top collaborators of Esa-Pekka Pälvimäki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Esa-Pekka Pälvimäki. Esa-Pekka Pälvimäki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 12 | |
| 2 | 13 | |
| 3 | 27 | |
| 4 | 25 | |
| 5 | 27 | |
| 6 | 165 | |
| 7 | 16 | |
| 8 | 1 | |
| 9 | 78 | |
| 10 | 25 | |
| 11 | 36 | |
| 12 | 15 |
About Esa-Pekka Pälvimäki
Esa-Pekka Pälvimäki is a scholar working on Cellular and Molecular Neuroscience, Psychiatry and Mental health and Pharmacology, having authored 12 papers that have together received 440 indexed citations. Recurring topics across this work include Neurotransmitter Receptor Influence on Behavior (11 papers), Receptor Mechanisms and Signaling (7 papers) and Treatment of Major Depression (3 papers). The work is most often cited by research in Cellular and Molecular Neuroscience (295 citations), Biological Psychiatry (39 citations) and Behavioral Neuroscience (26 citations). Esa-Pekka Pälvimäki has collaborated with scholars based in Finland and United States. Frequent co-authors include Jarmo Hietala, Erkka Syvälahti, Mikko Kuoppamäki, Aki Laakso, B Roth, Naseem Khan, Susan A. Berry, M S Choudhary, Bryan L. Roth and Nancy A. Sachs. Their work appears in journals such as Journal of Pharmacology and Experimental Therapeutics, Neuropsychopharmacology and Psychopharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.